
Dr Aayush Gupta
Professor and Head, Department of Dermatology, Venereology and Leprology
Dr. D.Y. Patil Medical College, Hospital and Research Centre, Dr. D.Y. Patil Vidyapeeth, Pimpri, Pune
- 102papers
- 748citations
- 12h-index
- 64first or senior author
- 7clinical trials as PI
- ₹7.5crore in grants
- 5patents
Aayush Gupta is Professor and Head of the Department of Dermatology, Venereology and Leprology at Dr. D.Y. Patil Medical College, Hospital and Research Centre, Dr. D.Y. Patil Vidyapeeth, Pimpri, Pune. He is Director of Strategic Initiatives at the medical college, heads the Bioprinting Laboratory of Dr. D.Y. Patil Vidyapeeth and directs the MD dermatology residency programme. He founded Qtanea Solutions Private Limited, which makes Vybe, a vibratory anaesthesia device, and OpenScholar, a research information platform for universities, and he holds five patents in India and the United States. He has published 102 papers, is principal investigator on seven industry clinical trials and has raised nearly ₹7.5 crore for research, made up of nine extramural research grants and a ₹50 lakh seed fund for his company Qtanea Solutions. His research covers vitiligo, ichthyosis and other genodermatoses, leprosy, wound healing and imaging with artificial intelligence.
- Speciality
- Dermatology
- Department
- Department of Dermatology, Venereology and Leprology
- Company
- Qtanea Solutions Private Limited
- University email
- aayush.gupta@dpu.edu.in
- Advisory work
- aayushggupta@gmail.com
- Address
- Sant Tukaram Nagar, Pimpri, Pune 411018, India
- Website
- aayushgupta.co
- Company email
- hello@qtanea.com
Appointments
At Dr. D.Y. Patil
- Professor and HeadDepartment of Dermatology, Venereology and Leprology
- Director of Strategic InitiativesDr. D.Y. Patil Medical College, Hospital and Research Centre
- Head, Bioprinting LaboratoryDr. D.Y. Patil Vidyapeeth
- Programme DirectorMD Dermatology residency
Industry and editorial
- Founder and CEOQtanea Solutions Private Limited
- Clinical Advisory BoardAdiuvo Diagnostics
- Scientific AdvisorClarivo Biosciences
- Consulting EditorClinical, Cosmetic and Investigational Dermatology
Awards
Two awards from the National Academy of Medical Sciences, the Lokmat Dhanvantri Award, two journal awards and a science fellowship in Japan.
- Dr A.S. Thambaiah AwardNational Academy of Medical Sciences, NAMSCON 2022, Jaipur
- Amritsar AwardNational Academy of Medical Sciences, 2022–23
- Dhanvantri AwardLokmat, 2023
- Two category awardsIndian Journal of Dermatology, Venereology and Leprology, Journal awards
- Sakura Science FellowJapan Science and Technology Agency, Fellowship in Japan
Memberships
- Indian Association of Dermatologists, Venereologists and Leprologistslife member
- International Society of DermatologyMember
- GUaRDIANrare-disease genomics consortium
Research programmes
Seven programmes, from the skin surface to the subcutis
- Above the skin surfaceImaging and diagnostics4 papers
- Stratum corneumIchthyosis and genodermatoses16 papers
- Basal layer and melanocytesVitiligo and pigment biology15 papers
- Epidermis and dermisProcedures and pain8 papers
- Dermal nervesLeprosy and infection15 papers
- DermisWound healing and tissue engineering2 papers
- The whole patientQuality of life11 papers
Clinical trials
Principal investigator on all 7
- Placebo-controlled · Sun PharmaSevere alopecia areata in adolescentsDeuruxolitinibSubmitted to DCGI
- Phase 0 · Johnson & JohnsonMultibacillary leprosy, treatment monitoringSkin assessment chart and plasma PGL-IOpens October 2026
- Phase 2 · Ahammune BiosciencesNon-segmental vitiligoTopical AB1001Opens October 2026
- Observational · Systopic LaboratoriesHair health in adultsH-Vit hair serumOpens October 2026
- Phase 4 · Johnson & JohnsonPsoriasisGuselkumab, subcutaneousOpens November 2026
- Phase 3 · Johnson & JohnsonMultibacillary leprosyBedaquiline with rifampicin and clofazimine (LIGHT)Under way since January 2025
- Registry · PfizerAtopic dermatitis, alopecia areata and vitiligoImmuno-dermatology disease registryStarted March 2025, completed
Research grants
₹7.5 crore in total
- CSIR-IGIB · ₹4.5 lakhSkin cell homeostasisPrincipal investigator · 2015 to 2017, completed
- Adiuvo Diagnostics · ₹3.5 lakhPortable fluorescence dermascope to identify the pathogens of skin infectionPrincipal investigator · 2019, completed
- ICMR · ₹67.8 lakhTopical transglutaminase-1 nanocomplex for enzyme replacement in autosomal recessive congenital ichthyosisPrincipal investigator, with CSIR-IGIB · 2019 to 2021, completed
- IADVL · ₹5 lakhMelanocyte and fibroblast cross-talk in keloidsPrincipal investigator · Since 2021, ongoing
- DBT · ₹85.5 lakhFully automated device that sprays a sterile bioscaffold carrying the patient’s own cellsPrincipal investigator, with CSIR-IGIB and BITS Pilani · Since 2023, ongoing
- ANRF · ₹3 croreSwitchable bispecific BCMA/CD19 CAR-T cell therapy for refractory systemic lupus erythematosusPrincipal investigator, with IIT Kanpur · Since December 2025, ongoing
- ANRF · ₹77 lakhImmune-competent 3D human skin model of vitiligoJoint principal investigator with Dr Rohit Kothari, with CSIR-IGIB · Since December 2025, ongoing
- ICMR · ₹85 lakhSkin-on-Chip for screening cosmetic endocrine disruptors relevant to PCOSJoint principal investigator with Dr Roopesh Rai · Since September 2026, ongoing
- DBT · ₹70.82 lakhNon-viral TGM1 delivery validated in a TGM1-deficient 3D human skin modelPrincipal investigator, with CSIR-IGIB · Starts December 2026
Patents
- United StatesPathogen detection deviceAdiuvo Diagnostics Pvt Ltd. Granted 13 December 2022.US 11,523,738
- IndiaFluorescence detection of pathogensAdiuvo Diagnostics Private Limited. Granted 22 October 2019.IN 323440
- IndiaDetection of cellular entitiesAdiuvo Diagnostics Private Limited. Granted 4 April 2025.IN 564943
- IndiaPunch biopsy instrumentDr. D.Y. Patil Vidyapeeth, Pune. Granted 31 January 2025.IN 559407
- IndiaPain-abating deviceDr. D.Y. Patil Vidyapeeth and Qtanea Solutions Pvt. Ltd. Granted 16 January 2024.IN 499691
Recent papers
- When biologics fail: Tofacitinib-induced remission in a child with severe, genetically ambiguous psoriasisIndian Journal of Dermatology, Venereology and Leprology2026Senior authorDOI
- Port-wine capillary malformationJournal of the American Academy of Dermatology2026DOI
- Measuring the composition and availability of human resources for health by sex in 204 countries and territories, 1990–2023, and workforce gaps for universal health coverage: a systematic analysis for the Global Burden of Disease Study 2023The Lancet Public Health2026DOI
- Comment on Case Series of Kaposi’s Varicelliform Eruption Associated with Underlying Primary DermatosesIndian Journal of Dermatology2026Senior authorDOI
- Nevus of OtaJournal of the American Academy of Dermatology2026DOI
- Global, regional, and national burden of HIV/AIDS, 1990–2023, with the estimated burden attributable to intimate partner violence and forecasted impacts of funding cuts through 2030: results from the Global Burden of Disease Study 2023The Lancet HIV2026DOI
- Decoding biological drug names in dermatology: The post-2022 WHO nomenclature revision and its implications for clinical practiceJournal of the American Academy of Dermatology2026Senior authorDOI
- Co-Occurrence of En Coup de Sabre, Parry-Romberg Syndrome, and Hemimasticatory Spasm: A Case ReportCase Reports in Dermatology2026Senior authorDOI
- microRNA miR-31-5p confers protection to melanin-deficient vitiligo keratinocytes against UV-B induced DNA damage by activating autophagy machineryScientific Reports2026DOI
- Revisiting Leonine Facies: Toward More Inclusive Differential DiagnosesIndian Dermatology Online Journal2026Senior authorDOI
Talks and media
- Lecture on SIRT1, vitiligo and skin cancerNAMSCON 2022 · Jaipur
- Award at the 62nd annual conference of the National Academy of Medical SciencesNAMSCON 2022 · Jaipur
- Honoured at ROOTS-VIII, the national conference on laser and aesthetic dermatologyJune 2025 · Pune
- Hands-on workshop at ROOTS-VIIIJune 2025 · Pune
- Opening of ROOTS-VIIIJune 2025 · Pune
- At the QS Higher Ed Summit: Asia Pacific 2025November 2025 · Korea University, Seoul
- With colleagues at the QS summitNovember 2025 · Korea University, Seoul
- Featured as the treating dermatologistTLC UK · Body Bizarre
- Featured as the treating dermatologistMedTech Innovator · Adiuvo Diagnostics